Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination Therapy of Rosuvastatin and Ezetimibe in Patients with High Cardiovascular Risk.
Yang YJ, Lee SH, Kim BS, Cho YK, Cho HJ, Cho KI, Kim SY, Ryu JK, Cho JM, Park JI, Park JS, Park CG, Chun WJ, Kim MA, Jin DK, Lee N, Kim BJ, Koh KK, Suh J, Lee SH, Lee BK, Oh SJ, Jin HY, Ahn Y, Lee SG, Bae JH, Park WJ, Lee SC, Lee HC, Lee J, Park C, Lee B, Jang Y. Yang YJ, et al. Among authors: park ji, park c, park js, park cg, park wj. Clin Ther. 2017 Jan;39(1):107-117. doi: 10.1016/j.clinthera.2016.11.014. Epub 2016 Dec 19. Clin Ther. 2017. PMID: 28007331 Clinical Trial.
Efficacies of the new paclitaxel-eluting Coroflex Please stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please and Taxus (ECO-PLEASANT) trial: study rationale and design.
Seo JB, Jeon HK, Park KW, Park JS, Bae JH, Kim SW, Moon KW, Choi JW, Lee SG, Chung WY, Youn TJ, Kim SJ, Kim DI, Kim BO, Hyon MS, Park KS, Cha TJ, Hwang HK, Hur SH, Kim HS. Seo JB, et al. Among authors: park kw, park js, park ks. Trials. 2009 Oct 23;10:98. doi: 10.1186/1745-6215-10-98. Trials. 2009. PMID: 19849864 Free PMC article. Clinical Trial.
Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents.
Li YJ, Rha SW, Chen KY, Poddar KL, Jin Z, Minami Y, Wang L, Dang Q, Li GP, Ramasamy S, Park JY, Choi CU, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ, Jeong MH, Ahn YK, Hong TJ, Park JS, Kim YJ, Hur SH, Seong IW, Chae JK, Cho MC, Bae JH, Choi DH, Jang YS, Chae IH, Kim HS, Kim CJ, Yoon JH, Ahn TH, Tahk SJ, Chung WS, Seung KB, Park SJ; other Korea Acute Myocardial infarction Registry Investigators. Li YJ, et al. Among authors: park jy, park js, park sj, park cg. Am Heart J. 2010 Apr;159(4):684-690.e1. doi: 10.1016/j.ahj.2009.12.041. Am Heart J. 2010. PMID: 20362730 Clinical Trial.
Gender differences in clinical features and in-hospital outcomes in ST-segment elevation acute myocardial infarction: from the Korean Acute Myocardial Infarction Registry (KAMIR) study.
Park JS, Kim YJ, Shin DG, Jeong MH, Ahn YK, Chung WS, Seung KB, Kim CJ, Cho MC, Jang YS, Park SJ, Seong IW, Chae SC, Hur SH, Choi DH, Hong TJ; Korean Acute Myocardial Infarction Registry (KAMIR) Group. Park JS, et al. Among authors: park sj. Clin Cardiol. 2010 Aug;33(8):E1-6. doi: 10.1002/clc.20557. Clin Cardiol. 2010. PMID: 20589943 Free PMC article.
Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry.
Choi CU, Rha SW, Oh DJ, Poddar KL, Na JO, Kim JW, Lim HE, Kim EJ, Park CG, Seo HS, Hong TJ, Park JS, Kim YJ, Hur SH, Seong IW, Chae JK, Cho MC, Bae JH, Choi DH, Jang YS, Chae IH, Kim HS, Kim CJ, Yoon JH, Ahn TH, Tahk SJ, Chung WS, Seung KB, Chae SC, Park SJ, Ahn YK, Jeong MH. Choi CU, et al. Among authors: park js, park sj, park cg. Am Heart J. 2011 Feb;161(2):373-382.e1-3. doi: 10.1016/j.ahj.2010.10.031. Epub 2011 Jan 15. Am Heart J. 2011. PMID: 21315222
Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.
Yang TH, Kim DI, Kim DK, Jang JS, Kim U, Seol SH, Kim DK, Hong GR, Park JS, Shin DG, Kim YJ, Cho YK, Nam CW, Hur SH, Kim KB, Kim DS. Yang TH, et al. Among authors: park js. Korean J Intern Med. 2011 Jun;26(2):145-52. doi: 10.3904/kjim.2011.26.2.145. Epub 2011 Jun 1. Korean J Intern Med. 2011. PMID: 21716590 Free PMC article.
The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial.
Cho YR, Kim YD, Park TH, Park K, Park JS, Baek H, Choi SY, Kim KS, Hong TJ, Yang TH, Hwang JY, Park JS, Hur SH, Lee SG. Cho YR, et al. Among authors: park js, park th, park k. Trials. 2011 Nov 22;12:247. doi: 10.1186/1745-6215-12-247. Trials. 2011. PMID: 22108275 Free PMC article. Clinical Trial.
Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
Lee SE, Kim YJ, Lee HY, Yang HM, Park CG, Kim JJ, Kim SK, Rhee MY, Oh BH; Investigators. Lee SE, et al. Clin Ther. 2012 Mar;34(3):552-568, 568.e1-9. doi: 10.1016/j.clinthera.2012.01.024. Epub 2012 Mar 3. Clin Ther. 2012. PMID: 22381711 Clinical Trial.
7,337 results